BioNexus Gene Lab Corp. Revenue Breakdown
No Revenue Breakdown for BGLC on this site yet.
- 2025-12-31: Others Not split by product in the filing$7.42M100.00%; Total revenue $7.42M.
- 2024-12-31: Others Not split by product in the filing$9.51M100.00%; Total revenue $9.51M.
- 2023-12-31: Others Not split by product in the filing$9.77M100.00%; Total revenue $9.77M.
- 2022-12-31: Others Not split by product in the filing$10.93M100.00%; Total revenue $10.93M.
Source checked: the stored Revenue Breakdown page for BGLC.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $7.42M 100.00% | $7.42M |
| 2024-12-31 | Not split by product in the filing $9.51M 100.00% | $9.51M |
| 2023-12-31 | Not split by product in the filing $9.77M 100.00% | $9.77M |
| 2022-12-31 | Not split by product in the filing $10.93M 100.00% | $10.93M |
| 2021-12-31 | Not split by product in the filing $13.36M 100.00% | $13.36M |
| 2020-12-31 | Not split by product in the filing $11.39M 100.00% | $11.39M |
| 2019-12-31 | $126.95K | |
| 2018-12-31 | $212.33K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $76.16K 100.00% | $76.16K |
| 2026-03-31 | Not split by product $22.84K 100.00% | $22.84K |
| 2025-12-31 | Not split by product $483.76K 100.00% | $483.76K |
| 2025-09-30 | Not split by product $2.54M 100.00% | $2.54M |
| 2025-06-30 | Not split by product $2.26M 100.00% | $2.26M |
| 2025-03-31 | Not split by product $2.14M 100.00% | $2.14M |
| 2024-12-31 | Not split by product $2.52M 100.00% | $2.52M |
| 2024-09-30 | Not split by product $2.63M 100.00% | $2.63M |
| 2024-06-30 | Not split by product $1.97M 100.00% | $1.97M |
| 2024-03-31 | Not split by product $2.38M 100.00% | $2.38M |
| 2023-12-31 | Not split by product $2.27M 100.00% | $2.27M |
| 2023-09-30 | Not split by product $2.55M 100.00% | $2.55M |
| 2023-06-30 | Not split by product $2.57M 100.00% | $2.57M |
| 2023-03-31 | Not split by product $2.38M 100.00% | $2.38M |
| 2022-12-31 | Not split by product $2.84M 100.00% | $2.84M |
| 2022-09-30 | Not split by product $2.58M 100.00% | $2.58M |
| 2022-06-30 | Not split by product $2.49M 100.00% | $2.49M |
| 2022-03-31 | Not split by product $3.03M 100.00% | $3.03M |
| 2021-12-31 | Not split by product $3.25M 100.00% | $3.25M |
| 2021-09-30 | Not split by product $3.58M 100.00% | $3.58M |
| 2021-06-30 | Not split by product $3.09M 100.00% | $3.09M |
| 2021-03-31 | Not split by product $3.45M 100.00% | $3.45M |
| 2020-12-31 | Not split by product $4.13M 100.00% | $4.13M |
| 2020-09-30 | Not split by product $3.09M 100.00% | $3.09M |
| 2020-06-30 | Not split by product $1.10M 100.00% | $1.10M |
| 2020-03-31 | Not split by product $3.07M 100.00% | $3.07M |
| 2019-12-31 | Not split by product $53.05K 100.00% | $53.05K |
| 2019-09-30 | Not split by product $24.17K 100.00% | $24.17K |
| 2019-06-30 | Not split by product $21.64K 100.00% | $21.64K |
| 2019-03-31 | Not split by product $28.09K 100.00% | $28.09K |
| 2018-12-31 | Not split by product $9.41K 100.00% | $9.41K |
| 2018-09-30 | Not split by product $91.63K 100.00% | $91.63K |
| 2018-06-30 | Not split by product $111.30K 100.00% | $111.30K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |